The therapeutic potential of TSC-EVs on wound healing was analyzed in our transcriptome analysis (Figs. 2 and 3), which also confirmed that anti-NGF treatment significantly inhibited the wound-healing effect of TSC-EVs (Fig. 7J, K, S8B). Here, NGF is linked to tuberous sclerosis.